SCHEMBL370626

SCHEMBL370626

Cn1cc(/C(CC(c2ccc(C(=O)NC3CC3)c(F)c2)c2ccccc2Cl)=N/O)ccc1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.37
CRHR1 P34998 2/20 0.35
BRD4 O60885 5/20 0.35
F10 P00742 1/20 0.35
MAPK14 Q16539 3/20 0.34
P2RX7 Q99572 1/20 0.34
TRIM24 O15164 1/20 0.34
BRD1 O95696 1/20 0.34
CCL2 P13500 1/20 0.34
TAF1 P21675 1/20 0.34
BRD2 P25440 1/20 0.34
SMARCA2 P51531 1/20 0.34
SMARCA4 P51532 1/20 0.34
BRPF1 P55201 1/20 0.34
EP300 Q09472 1/20 0.34
BPTF Q12830 1/20 0.34
CACNA1C Q13936 1/20 0.34
BRD3 Q15059 1/20 0.34
BRDT Q58F21 1/20 0.34
ATAD2 Q6PL18 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389652 1.00 HPGD (0.37) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1389650 1.00 HPGD (0.37) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1390041 0.97 BRD4 (0.40) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1390039 0.97 BRD4 (0.40) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1390043 0.97 BRD4 (0.40) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1390036 0.97 BRD4 (0.40) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1389760 0.97 HPGD (0.35) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1389763 0.97 HPGD (0.35) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1389766 0.97 HPGD (0.35) HPGDCRHR1BRD4F10MAPK14
SCHEMBL1390035 0.97 BRD4 (0.40) HPGDCRHR1BRD4F10MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 HPGD 602/4885CRHR1 174/4885BRD4 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.